Accéder au contenu
Merck

Exercise during pregnancy mitigates Alzheimer-like pathology in mouse offspring.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2011-09-29)
Arne Herring, Anja Donath, Maksym Yarmolenko, Ellen Uslar, Catharina Conzen, Dimitrios Kanakis, Claudius Bosma, Karl Worm, Werner Paulus, Kathy Keyvani
RÉSUMÉ

Physical activity protects brain function in healthy individuals and those with Alzheimer's disease (AD). Evidence for beneficial effects of parental exercise on the health status of their progeny is sparse and limited to nondiseased individuals. Here, we questioned whether maternal running interferes with offspring's AD-like pathology and sought to decipher the underlying mechanisms in TgCRND8 mice. Maternal stimulation was provided by voluntary wheel running vs. standard housing during pregnancy. Following 5 mo of standard housing of transgenic and wild-type offspring, their brains were examined for AD-related pathology and/or plasticity changes. Running during pregnancy reduced β-amyloid (Aβ) plaque burden (-35%, P=0.017) and amyloidogenic APP processing in transgenic offspring and further improved the neurovascular function by orchestrating different Aβ transporters and increasing angiogenesis (+29%, P=0.022). This effect was accompanied by diminished inflammation, as indicated by reduced microgliosis (-20%, P=0.002) and down-regulation of other proinflammatory mediators, and resulted in less oxidative stress, as nitrotyrosine levels declined (-28%, P=0.029). Moreover, plasticity changes (in terms of up-regulation of reelin, synaptophysin, and ARC) were found not only in transgenic but also in wild-type offspring. We conclude that exercise during pregnancy provides long-lasting protection from neurodegeneration and improves brain plasticity in the otherwise unstimulated progeny.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-reeline (mreeline, a.a. 164-496), clone G10, clone G10, Chemicon®, from mouse
Sigma-Aldrich
3-Nitro-L-tyrosine, crystalline
Sigma-Aldrich
Anti-Dab1 (C-terminal), ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-LRP, Light Chain Mouse mAb (5A6), liquid, clone 5A6, Calbiochem®